Generic name: ALENDRONATE SODIUM 70mg
Dosage form: tablet, effervescent
Medically reviewed by Drugs.com. Last updated on Nov 3, 2020.
Treatment of Osteoporosis in Postmenopausal Women
Treatment to Increase Bone Mass in Men With Osteoporosis
Important Administration Instructions
i. Take BINOSTO upon arising for the day and at least 30 minutes before the first food, beverage, or medication of the day.
• Patients should not swallow the undissolved effervescent tablet, should not chew the effervescent tablet or allow the effervescent tablet to dissolve in their mouths because of the risk for oropharyngeal irritation [see Warnings and Precautions (5.1)].
Dissolve the effervescent tablet in 4 ounces room temperature plain water only (not mineral water or flavored water).
ii. Wait at least 5 minutes after the effervescence stops and then stir the buffered solution for approximately 10 seconds and ingest.
iii. Avoid lying down for at least 30 minutes after taking BINOSTO and until after their first food of the day.
iv. Do not take BINOSTO at bedtime or before arising for the day.
Failure to follow these instructions may increase the risk of esophageal adverse reactions [see Warnings and Precautions (5.1)].
Recommendations for Calcium and Vitamin D Supplementation
Instruct patients to take supplemental calcium and vitamin D if dietary intake is inadequate [see Warnings and Precautions ( 5.2)] . Patients at increased risk for vitamin D insufficiency (e.g., over the age of 70 years, nursing home-bound, or chronically ill) may need vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplementation and measurement of 25-hydroxyvitamin D should be considered.
Frequently asked questions
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Binosto (alendronate)
- Side Effects
- During Pregnancy or Breastfeeding
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: bisphosphonates
- FDA Alerts (3)
- FDA Approval History
Other brands: Fosamax